Literature DB >> 18969312

A sorbent tube for oral malodour monitoring.

Julio Rodríguez-Fernández1, Regina López-Fernández, Rosario Pereiro, Manuel Menéndez, José María Tejerina, Alberto Sicilia, Alfredo Sanz-Medel.   

Abstract

Volatile sulphur compounds (VSCs) and particularly hydrogen sulphide are considered as the predominant gases causing oral malodour. In this paper, a simple alarm sensor has been developed for VSCs determination in mouth air. The device consists of a glass tube packed with a solid sensing phase. The VSCs react with the sensing phase to produce a change in the colour of the sensor visible with a naked eye. Different "reagents" were investigated to develop the sensing phase (neocuproine + Cu(II), bathocuproine + Cu(II), resazurin, 2,6-dichlorophenolindophenol and lead acetate), finding the neocuproine + Cu(II) as the best for our purposes. Also, different substrates such as Amberlite XAD-4 and XAD-7 and different trademarks of silica gel were tested as solid supports, being selected the silica gel. A device consisting of a glass tube packed with the sensing phase was optimized and tested with halitosis patients as a rapid illness test and the results compared with those obtained with a commercially available instrument, the Halimetertrade mark, used for the determination of VSCs in mouth air. The results exhibited acceptable agreement between the proposed "qualitative" alarm sensor and a commercially available technique selected as reference, showing the possibility of using this "visual sensor" to control the halitosis and its evolution with an eventual treatment, by the own patient.

Entities:  

Year:  2004        PMID: 18969312     DOI: 10.1016/j.talanta.2003.08.014

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  1 in total

1.  Self-reported halitosis and emotional state: impact on oral conditions and treatments.

Authors:  Salvatore Settineri; Carmela Mento; Simona C Gugliotta; Ambra Saitta; Antonella Terranova; Giuseppe Trimarchi; Domenico Mallamace
Journal:  Health Qual Life Outcomes       Date:  2010-03-26       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.